+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Peptide Therapeutics Market Intelligence Report - Global Forecast to 2027

  • PDF Icon

    Report

  • 125 Pages
  • July 2022
  • Region: Global
  • Think Market Intelligence
  • ID: 5624184
UP TO OFF until Dec 31st 2022
The Global Peptide Therapeutics Market is projected to reach USD 50.72 billion by 2027 from USD 27.13 billion in 2021, at a CAGR 10.99% during the forecast period.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

  • The Americas Peptide Therapeutics Market size was estimated at USD 9,961.11 million in 2021, is expected to reach USD 10,955.95 million in 2022, and is projected to grow at a CAGR of 10.64% to reach USD 18,276.41 million by 2027.
  • The Asia-Pacific Peptide Therapeutics Market size was estimated at USD 7,286.99 million in 2021, is expected to reach USD 8,218.47 million in 2022, and is projected to grow at a CAGR of 11.62% to reach USD 14,099.32 million by 2027.
  • The Europe, Middle East & Africa Peptide Therapeutics Market size was estimated at USD 9,886.49 million in 2021, is expected to reach USD 10,932.62 million in 2022, and is projected to grow at a CAGR of 10.85% to reach USD 18,349.81 million by 2027.

Market Segmentation & Coverage:


The report on peptide therapeutics identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. This market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the peptide therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:

Technology:

  • Hybrid Phase
  • Liquid Phase
  • Solid Phase

API Type:

  • CMO
  • In-house

Drug Class:

  • Calcitonins
  • Glucagon & Analogs
  • Insulins
  • Luteinizing Hormone-Releasing Hormone
  • Somatostatins
  • Vasopressin

Application:

  • Anti-infective
  • Cancer
  • Cardio Vascular Disease Respiratory
  • Central Nervous System
  • Dermatology
  • Gastrointestinal
  • Metabolic
  • Renal

End User:

  • Hospitals
  • Pharmaceutical Industries
  • Research Laboratories

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
  • Europe, Middle East & Africa
    • France
    • Germany
    • Italy
    • Netherlands
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • AmbioPharm Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bachem Holding AG
  • Bristol-Myers Squibb Company
  • CordenPharma International
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Hemmo Pharmaceuticals Pvt Ltd.
  • Ipsen S.A.
  • Merck & Co., Inc.
  • Novartis International AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • PolyPeptide Group
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Zealand Pharma A/S
Frequently Asked Questions about the Peptide Therapeutics Market

What is the estimated value of the Peptide Therapeutics Market?

The Peptide Therapeutics Market was estimated to be valued at $27.13 Billion in 2021.

What is the growth rate of the Peptide Therapeutics Market?

The growth rate of the Peptide Therapeutics Market is 10.9%, with an estimated value of $50.72 Billion by 2027.

What is the forecasted size of the Peptide Therapeutics Market?

The Peptide Therapeutics Market is estimated to be worth $50.72 Billion by 2027.

Who are the key companies in the Peptide Therapeutics Market?

Key companies in the Peptide Therapeutics Market include AmbioPharm Inc., Amgen Inc., AstraZeneca PLC, Bachem Holding AG, Bristol, Myers Squibb Company, CordenPharma International, Eli Lilly and Company and La Roche AG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Market Overview
4. Americas Peptide Therapeutics Market
4.1. Introduction
4.2. Argentina
4.3. Brazil
4.4. Canada
4.5. Mexico
4.6. United States
5. Asia-Pacific Peptide Therapeutics Market
5.1. Introduction
5.2. Australia
5.3. China
5.4. India
5.5. Indonesia
5.6. Japan
5.7. Malaysia
5.8. Philippines
5.9. Singapore
5.10. South Korea
5.11. Taiwan
5.12. Thailand
6. Europe, Middle East & Africa Peptide Therapeutics Market
6.1. Introduction
6.2. France
6.3. Germany
6.4. Italy
6.5. Netherlands
6.6. Qatar
6.7. Russia
6.8. Saudi Arabia
6.9. South Africa
6.10. Spain
6.11. United Arab Emirates
6.12. United Kingdom
7. Company Usability Profiles
7.1. AmbioPharm Inc.
7.2. Amgen Inc.
7.3. AstraZeneca PLC
7.4. Bachem Holding AG
7.5. Bristol-Myers Squibb Company
7.6. CordenPharma International
7.7. Eli Lilly and Company
7.8. F. Hoffmann-La Roche AG
7.9. GlaxoSmithKline PLC
7.10. Hemmo Pharmaceuticals Pvt Ltd.
7.11. Ipsen S.A.
7.12. Merck & Co., Inc.
7.13. Novartis International AG
7.14. Novo Nordisk A/S
7.15. Pfizer Inc.
7.16. PolyPeptide Group
7.17. Sanofi S.A.
7.18. Takeda Pharmaceutical Company Limited
7.19. Teva Pharmaceutical Industries Ltd.
7.20. Zealand Pharma A/S
List of Figures
Figure 1. Global Peptide Therapeutics Market: Research Process
Figure 2. Global Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 3. Global Peptide Therapeutics Market Size, by Region, 2021 Vs 2027 (%)
Figure 4. Global Peptide Therapeutics Market Size, by Region, 2021 Vs 2027 (USD Million)
Figure 5. Competitive Strategic Window For Global Peptide Therapeutics Market Size, by Region, 2027
Figure 6. Americas Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 7. Americas Peptide Therapeutics Market Size, by Country, 2021 Vs 2027 (%)
Figure 8. Americas Peptide Therapeutics Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 9. Competitive Strategic Window For Americas Peptide Therapeutics Market Size, by Country, 2027
Figure 10. Argentina Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 11. Brazil Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 12. Canada Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 13. Mexico Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 14. United States Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 15. United States Peptide Therapeutics Market Size, by State, 2021 Vs 2027 (%)
Figure 16. United States Peptide Therapeutics Market Size, by State, 2021 Vs 2027 (USD Million)
Figure 17. Competitive Strategic Window For United States Peptide Therapeutics Market Size, by State, 2027
Figure 18. Asia-Pacific Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 19. Asia-Pacific Peptide Therapeutics Market Size, by Country, 2021 Vs 2027 (%)
Figure 20. Asia-Pacific Peptide Therapeutics Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 21. Competitive Strategic Window For Asia-Pacific Peptide Therapeutics Market Size, by Country, 2027
Figure 22. Australia Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 23. China Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 24. India Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 25. Indonesia Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 26. Japan Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 27. Malaysia Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 28. Philippines Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 29. Singapore Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 30. South Korea Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 31. Taiwan Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 32. Thailand Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 33. Europe, Middle East & Africa Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 34. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Country, 2021 Vs 2027 (%)
Figure 35. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 36. Competitive Strategic Window For Europe, Middle East & Africa Peptide Therapeutics Market Size, by Country, 2027
Figure 37. France Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 38. Germany Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 39. Italy Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 40. Netherlands Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 41. Qatar Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 42. Russia Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 43. Saudi Arabia Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 44. South Africa Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 45. Spain Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 46. United Arab Emirates Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Figure 47. United Kingdom Peptide Therapeutics Market Size, 2019-2027 (USD Million)
List of Tables
Table 1. Global Peptide Therapeutics Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. Global Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 4. Global Peptide Therapeutics Market Size, by Region, 2019-2027 (USD Million)
Table 5. Global Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 6. Global Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 7. Global Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 8. Global Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 9. Global Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 10. Americas Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 11. Americas Peptide Therapeutics Market Size, by Country, 2019-2027 (USD Million)
Table 12. Americas Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 13. Americas Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 14. Americas Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 15. Americas Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 16. Americas Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 17. Argentina Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 18. Argentina Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 19. Argentina Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 20. Argentina Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 21. Argentina Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 22. Argentina Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 23. Brazil Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 24. Brazil Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 25. Brazil Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 26. Brazil Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 27. Brazil Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 28. Brazil Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 29. Canada Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 30. Canada Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 31. Canada Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 32. Canada Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 33. Canada Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 34. Canada Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 35. Mexico Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 36. Mexico Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 37. Mexico Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 38. Mexico Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 39. Mexico Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 40. Mexico Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 41. United States Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 42. United States Peptide Therapeutics Market Size, by State, 2019-2027 (USD Million)
Table 43. United States Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 44. United States Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 45. United States Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 46. United States Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 47. United States Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 48. Asia-Pacific Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 49. Asia-Pacific Peptide Therapeutics Market Size, by Country, 2019-2027 (USD Million)
Table 50. Asia-Pacific Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 51. Asia-Pacific Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 52. Asia-Pacific Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 53. Asia-Pacific Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 54. Asia-Pacific Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 55. Australia Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 56. Australia Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 57. Australia Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 58. Australia Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 59. Australia Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 60. Australia Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 61. China Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 62. China Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 63. China Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 64. China Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 65. China Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 66. China Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 67. India Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 68. India Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 69. India Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 70. India Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 71. India Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 72. India Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 73. Indonesia Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 74. Indonesia Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 75. Indonesia Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 76. Indonesia Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 77. Indonesia Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 78. Indonesia Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 79. Japan Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 80. Japan Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 81. Japan Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 82. Japan Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 83. Japan Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 84. Japan Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 85. Malaysia Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 86. Malaysia Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 87. Malaysia Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 88. Malaysia Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 89. Malaysia Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 90. Malaysia Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 91. Philippines Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 92. Philippines Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 93. Philippines Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 94. Philippines Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 95. Philippines Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 96. Philippines Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 97. Singapore Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 98. Singapore Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 99. Singapore Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 100. Singapore Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 101. Singapore Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 102. Singapore Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 103. South Korea Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 104. South Korea Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 105. South Korea Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 106. South Korea Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 107. South Korea Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 108. South Korea Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 109. Taiwan Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 110. Taiwan Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 111. Taiwan Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 112. Taiwan Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 113. Taiwan Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 114. Taiwan Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 115. Thailand Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 116. Thailand Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 117. Thailand Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 118. Thailand Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 119. Thailand Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 120. Thailand Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 121. Europe, Middle East & Africa Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 122. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Country, 2019-2027 (USD Million)
Table 123. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 124. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 125. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 126. Europe, Middle East & Africa Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 127. Europe, Middle East & Africa Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 128. France Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 129. France Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 130. France Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 131. France Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 132. France Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 133. France Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 134. Germany Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 135. Germany Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 136. Germany Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 137. Germany Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 138. Germany Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 139. Germany Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 140. Italy Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 141. Italy Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 142. Italy Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 143. Italy Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 144. Italy Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 145. Italy Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 146. Netherlands Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 147. Netherlands Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 148. Netherlands Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 149. Netherlands Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 150. Netherlands Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 151. Netherlands Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 152. Qatar Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 153. Qatar Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 154. Qatar Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 155. Qatar Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 156. Qatar Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 157. Qatar Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 158. Russia Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 159. Russia Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 160. Russia Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 161. Russia Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 162. Russia Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 163. Russia Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 164. Saudi Arabia Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 165. Saudi Arabia Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 166. Saudi Arabia Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 167. Saudi Arabia Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 168. Saudi Arabia Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 169. Saudi Arabia Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 170. South Africa Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 171. South Africa Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 172. South Africa Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 173. South Africa Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 174. South Africa Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 175. South Africa Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 176. Spain Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 177. Spain Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 178. Spain Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 179. Spain Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 180. Spain Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 181. Spain Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 182. United Arab Emirates Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 183. United Arab Emirates Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 184. United Arab Emirates Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 185. United Arab Emirates Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 186. United Arab Emirates Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 187. United Arab Emirates Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)
Table 188. United Kingdom Peptide Therapeutics Market Size, 2019-2027 (USD Million)
Table 189. United Kingdom Peptide Therapeutics Market Size, by Technology, 2019-2027 (USD Million)
Table 190. United Kingdom Peptide Therapeutics Market Size, by Api Type, 2019-2027 (USD Million)
Table 191. United Kingdom Peptide Therapeutics Market Size, by Drug Class, 2019-2027 (USD Million)
Table 192. United Kingdom Peptide Therapeutics Market Size, by Application, 2019-2027 (USD Million)
Table 193. United Kingdom Peptide Therapeutics Market Size, by End User, 2019-2027 (USD Million)

Companies Mentioned

  • AmbioPharm Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bachem Holding AG
  • Bristol-Myers Squibb Company
  • CordenPharma International
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Hemmo Pharmaceuticals Pvt Ltd.
  • Ipsen S.A.
  • Merck & Co., Inc.
  • Novartis International AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • PolyPeptide Group
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Zealand Pharma A/S

Methodology

Loading
LOADING...